They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE) and lupus nephritis, two new studies suggest.

Western Mass News stopped by to see for ourselves and we found at least four syringes mixed in with other litter just as Wiggins described. When we looked up from the paraphernalia, we could see ...

A RECENT investigation carried out in this laboratory revealed that rats treated with glucagon gained less weight and contained much less fat, protein and water than pair-fed controls. Since the ...

Unger, R. H., and Eisentraut, A. M., Hormones in Blood, 1 (edit. by Gray, C. H., and Bacharach, A. L.), 113 (Academic Press, London, 1967).

Image credit: Shutterstock / Art_Photo. Amneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE) prefilled syringe autoinjector to treat tough-to-treat ...

prefilled syringe autoinjector for the acute treatment of migraine with or without aura and cluster headache in adults. Second, Amneal has received approval from the FDA for exenatide, which is the ...

Police are looking into the discovery of hundreds of needles and syringes along the foreshore in Rifle Range in Vatuwaqa. Local photographer Pita Simpson says the discovery was made by his brother and ...

Study: Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review. Image Credit: Kmpzzz/Shutterstock.com In a recent study published ...

Nesfatin-1 infusion in the small intestine of NUCB2-knockout rats reduced hepatic glucose production via a gut – brain – liver circuit. Mechanistically, NUCB2/nesfatin-1 interacted directly with ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce ...